132 related articles for article (PubMed ID: 18363145)
1. Assessment of drug release from oil depot formulations using an in vitro model -- potential applicability in accelerated release testing.
Larsen SW; Jessen MN; Ostergaard J; Larsen C
Drug Dev Ind Pharm; 2008 Mar; 34(3):297-304. PubMed ID: 18363145
[TBL] [Abstract][Full Text] [Related]
2. In vitro release from oil injectables for intra-articular administration: Importance of interfacial area, diffusivity and partitioning.
Thing M; Larsen C; Østergaard J; Jensen H; Larsen SW
Eur J Pharm Sci; 2012 Feb; 45(3):351-7. PubMed ID: 22178293
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration.
Larsen SW; Østergaard J; Friberg-Johansen H; Jessen MN; Larsen C
Eur J Pharm Sci; 2006 Dec; 29(5):348-54. PubMed ID: 16920337
[TBL] [Abstract][Full Text] [Related]
4. In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration.
Pedersen BT; Larsen SW; Østergaard J; Larsen C
Drug Deliv; 2008 Jan; 15(1):23-30. PubMed ID: 18197520
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration.
Pedersen BT; Ostergaard J; Larsen SW; Cornett C; Ankersen M; Larsen C
Drug Dev Ind Pharm; 2011 Jan; 37(1):62-71. PubMed ID: 20545510
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of drug substances in oily solutions. Drug release rate, partitioning and solubility.
Larsen DB; Parshad H; Fredholt K; Larsen C
Int J Pharm; 2002 Jan; 232(1-2):107-17. PubMed ID: 11790494
[TBL] [Abstract][Full Text] [Related]
7. Role of in vitro release models in formulation development and quality control of parenteral depots.
Larsen C; Larsen SW; Jensen H; Yaghmur A; Ostergaard J
Expert Opin Drug Deliv; 2009 Dec; 6(12):1283-95. PubMed ID: 19941410
[TBL] [Abstract][Full Text] [Related]
8. Isotropic medium chain mono-diglyceride/oil/water formulations for solubilization of lipophilic and hydrophilic drugs.
Sari P; Razzak M; Tucker IG
Int J Pharm; 2004 Feb; 270(1-2):287-96. PubMed ID: 14726143
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug lipophilicity on in vitro release rate from oil vehicles using nicotinic acid esters as model prodrug derivatives.
Weng Larsen S; Engelbrecht Thomsen AE; Rinvar E; Friis GJ; Larsen C
Int J Pharm; 2001 Mar; 216(1-2):83-93. PubMed ID: 11274810
[TBL] [Abstract][Full Text] [Related]
10. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content.
Montenegro L; Carbone C; Condorelli G; Drago R; Puglisi G
Drug Dev Ind Pharm; 2006 Jun; 32(5):539-48. PubMed ID: 16720409
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds.
Larsen SW; Frost AB; Østergaard J; Marcher H; Larsen C
Eur J Pharm Sci; 2008 May; 34(1):37-44. PubMed ID: 18374550
[TBL] [Abstract][Full Text] [Related]
12. Modification of in vitro drug release rate from oily parenteral depots using a formulation approach.
Fredholt K; Larsen DH; Larsen C
Eur J Pharm Sci; 2000 Sep; 11(3):231-7. PubMed ID: 11042229
[TBL] [Abstract][Full Text] [Related]
13. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
14. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
Mitchell SA; Balwinski KM
J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
[TBL] [Abstract][Full Text] [Related]
15. In vivo release of bupivacaine from subcutaneously administered oily solution. Comparison with in vitro release.
Larsen DB; Joergensen S; Olsen NV; Hansen SH; Larsen C
J Control Release; 2002 May; 81(1-2):145-54. PubMed ID: 11992687
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion: An Advanced Vehicle For Efficient Drug Delivery.
Ali A; Ansari VA; Ahmad U; Akhtar J; Jahan A
Drug Res (Stuttg); 2017 Nov; 67(11):617-631. PubMed ID: 28738427
[TBL] [Abstract][Full Text] [Related]
18. Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics.
Söderberg L; Dyhre H; Roth B; Björkman S
Anesthesiology; 2006 Jan; 104(1):110-21. PubMed ID: 16394697
[TBL] [Abstract][Full Text] [Related]
19. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
Galal S; El Massik MA; Abdallah OY; Daabis NA
Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the rotating dialysis cell as an in vitro model potentially useful for simulation of the pharmacokinetic fate of intra-articularly administered drugs.
Pedersen BT; Ostergaard J; Larsen SW; Larsen C
Eur J Pharm Sci; 2005 May; 25(1):73-9. PubMed ID: 15854803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
